PIMA182923

Hepatitis C Virus NS5 Monoclonal Antibody (BGN/1246/5G7), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA182923-Each-of-1 In Stock ₹ 52,465.50

PIMA182923 - Each of 1

₹ 52,465.50

In Stock

Quantity

1

Base Price: ₹ 52,465.50

GST (18%): ₹ 9,443.79

Total Price: ₹ 61,909.29

Antigen

Hepatitis C Virus NS5

Classification

Monoclonal

Concentration

1 mg/mL

Formulation

PBS with 0.09% sodium azide

Host Species

Mouse

Purification Method

Protein A

Regulatory Status

RUO

Target Species

Virus

Product Type

Antibody

Isotype

IgG1

Applications

ELISA, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin), Western Blot

Clone

BGN/1246/5G7

Conjugate

Unconjugated

Gene Alias

HCV; HCV NS5; Hepatitis C Virus; HepC; HepC NS5; NICE-3

Immunogen

Synthetic peptide corresponding to the NS-5 antigen region of the native protein.

Quantity

200 μg

Primary or Secondary

Primary

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Related Products

Img

Thermo Scientific

PIMA121399

--

Img

Thermo Scientific

PIMA518031

--

Img

Thermo Scientific

PIMA518088

--

Img

Thermo Scientific

PIPA562868

--

Img

Thermo Scientific

PIPA581508

--

Img

Thermo Scientific

PIPA581811

--

Img

Thermo Scientific

PIPA557363

--

Img

Thermo Scientific

PIMA531775

--

Description

  • In Western blot, this antibody detects a major band of ∽50 kDa with minor bands at ∽35, ∽40, and ∽67 kDa
  • This reflects bands found in DTT reduced blots fo the immunizing antigen and in immunoblots using a known antibody-positive serum
  • HCV is a positive, single-stranded RNA virus in the Flaviviridae family
  • The genome is approximately 10,000 nucleotides and encodes a single polyprotein of about 3,000 amino acids
  • The polyprotein is processed by host cell and viral proteases into three major structural proteins and several non-structural protein necessary for viral replication
  • Several different genotypes of HCV with slightly different genomic sequences have since been identified that correlate with differences in response to treatment with interferon alpha.